International Agencies

This document outlines the United States Government's global TB strategy.

This document presents guidance on the design and implementation of surveys and surveillance systems to measure the burden and trends of drug-resistant tuberculosis.

This facilitators’ guide for training community health workers and community volunteers is intended for training in tuberculosis (TB) and integration of TB prevention and care services into community-based activities.

This is the 20th global report on tuberculosis (TB) published by WHO in a series that started in 1997. It provides a comprehensive and up-to-date assessment of the TB epidemic and progress in implementing and financing TB prevention, care and control at global, regional and country levels using data reported by 200 countries and territories that account for over 99% of the world’s TB cases.

This document highlights strategic directions to integrate digital health into TB prevention and care activities in support of WHO’s End TB Strategy.

This document provides practical guidance on translating the World Health Organization's principles and recommendations into a national or local screening strategy.

This plan is based on the End TB strategy. Specifically it speaks about preventing TB, active case finding and contact tracing, focusing attention to key vulnerable and marginalized groups, development and roll out of new tools, and implementing TB services packages that are comprehensive and work in different types of epidemic and socioeconomic environments.

The primary purposes of this framework are to: 1) promote, enhance, and intensify TB research and innovation at the country level, and 2) promote, enhance, and catalyze TB research at the global level through advocacy, innovation, discussion of global priorities, and the development of networks for research and capacity building.

This report analyses the factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. Detailed pricing profiles of key DR-TB drugs are also provided.

This report details the steps that governments of countries with high burdens of TB-HIV and their partners have taken to turn a coordinated response to TB-HIV into reality at the country level, as well as the remaining gaps.